Fundz

Spruce Biosciences Appoints Daven Mody as Senior VP of Regulatory and Quality, Bruno Gagnon as Senior VP of Clinical Development Operations

PUBLIC · SPRBFeb 03, 2026

Position

Senior Vice President

Company

Spruce Biosciences

Bruno Gagnon
South San FranciscoBiotechnology

Description

Spruce Biosciences announced the appointments of Daven Mody and Bruno Gagnon as Senior Vice Presidents. Mody will lead Regulatory and Quality efforts, while Gagnon will oversee Clinical Development Operations.

Who to call at Spruce Biosciences, and when

A new leader at Spruce Biosciences brings new priorities and often new vendors. The first weeks are when they listen.

  • An alert the day Spruce Biosciences raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Spruce Biosciences, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Spruce Biosciences. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Spruce Biosciences

Location

611 Gateway Boulevard, Suite 740

South San Francisco, California, United States

About

Spruce Biosciences, Inc. is a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for neurological disorders. The company aims to address significant unmet medical needs through innovative treatment solutions. Spruce has a particular focus on rare diseases and is committed to serving patient communities. They are known for their work in enzyme replacement therapies.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Spruce Biosciences changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Alexis
Senior decision-maker at this company
••••••••@••••••••

See Alexis's verified email →

Anna
Senior decision-maker at this company
••••••••@••••••••

See Anna's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for Spruce Biosciences's next move

Learn about Strategic plan

Spruce Biosciences changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.